Gapping down
In reaction to earnings/guidance:
- RAD -6.5%, KBH -4.1%, FUL -2.3%, CNXC -2.1%, DRI -0.5%
Other news:
- PRTG -29.9% (files for $200 mln mixed securities shelf offering)
- DQ -9.7% (US to block some solar goods made in Xinjiang region, according to Bloomberg)
- TALO -6.2% (prices secondary offering of 5 mln shares of common stock; additional terms not disclosed)
- BIIB -6% (Biogen and Eisai receive FDA Breakthrough Therapy designation for lecanemab)
- BNL -4.7% (prices offering of 10 mln shares of common stock at $23.00 per share)
- OSW -2.5% (prices offering of 8,421,053 secondary common shares by selling shareholders at $9.50 per share)
- JKS -1.8% (US to block some solar goods made in Xinjiang region, according to Bloomberg)
- HIW -1.6% (sells property)
- THC -1.5% (MPW to acquire five hospitals from THC for $900 mln)
- BSY -1.1% (prices offering of $500.0 mln of convertible senior notes due 2027)
Analyst comments:
- DLTR -1.3% (downgraded to Neutral from Overweight at Piper Sandler)
- LMNL -1% (downgraded to Neutral from Buy at H.C. Wainwright)